Computational Studies about the Interactions of Nanomaterials with
  Proteins and their Impacts by An, Deyi et al.
Computational Studies about the Interactions of Nanomaterials with Proteins 
and their Impacts
*
 
 
An De-Yi(安德义)a)b), Su Ji-Guo(苏计国)b), Li Chun-Hua(李春华)c)†, and Li 
Jing-Yuan(李敬源)a)‡ 
 
a)
CAS Key Lab for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, 
Chinese Academy of Science, Beijing 100049, China 
b)
College of Science, Yanshan University, Qinhuangdao 066004, China 
 c)
College of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, China 
 
 
 
Intensive concerns about the biosafety of nanomaterials demand the systematic study 
of the mechanisms about their biological effects. Many biological effects can be 
attributed to the interaction of nanomaterials with protein and their impacts on protein 
function. On the other hand, nanomaterials exhibit the potential in a variety of 
biomedical applications, many of which also involve the direct interaction with 
protein. In this paper, we review some recent computational studies about this subject, 
especially the interaction of carbon and gold nanomaterials. Besides the hydrophobic 
and π-stacking interactions, the interaction mode of carbon nanomaterials can be 
regulated by their functional groups. And the coating of gold nanomaterials also 
adjusts their interaction mode, in addition to the coordination interaction with 
cysteine’s sulfur group and histidine’s imidazole group. Moreover, nanomaterials can 
interact with multiple proteins and the impacts on protein activity are attributed to a 
wide spectrum of mechanisms. The findings about the mechanisms of 
nanomaterial-protein interaction can further guide the design and development of 
nanomaterial to realize the applications in disease diagnosis and treatment. 
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1. Introduction 
Because of their small size and/or nanostructure, nanomaterials often have large 
specific surface area and produce quantum effects.
[1,2]
 Both endow nanomaterials with 
a variety of unique physical and chemical properties,
[3-5]
 leading to the application in 
different areas including healthcare, electronics, cosmetics and textiles. In the 
meantime, intensive attentions have been paid to the biological safety of 
nanomaterials.
[6,7]
 However, the potential threats of nanomaterials to human health 
especially the corresponding mechanisms largely remain elusive. On the other hand, 
nanomaterials exhibit promising potential in biomedical researches, e.g. drug delivery, 
diagnosis, bioimaging, and therapeutic agents.
[8-14]
 Many biological effects of 
nanomaterials (both positive and negative) are related to their impacts on the structure 
and function of protein. Hence, the studies about the interaction with protein and 
subsequent impact on protein function are crucial to a better understanding of the 
biological effect of nanomaterial. However, the metabolic processes of nanomaterials 
are very complicated in nature. For example, various proteins can adsorb on the 
surface of nanomaterial and form protein corona. The composition and content of 
protein within corona are very complicated and keep developing.
[15]
 Hence, it is very 
difficult to elucidate the underlying mechanism of a given biological effect. On top of 
this, relevant studies were often hampered by the limitation of spatial and temporal 
resolution of experimental techniques.
[16]
  
With the development of force field and the improvement of sampling efficiency as 
well as computing power, computational methods are widely applied to study a 
variety of biological processes and drug designs. They have also been proven to be 
powerful in the research about the biological effect of nanomaterials. Based on 
computational studies, the interaction between nanomaterials and proteins and the 
impacts on the structure and function of biological molecules can be effectively 
identified. Moreover, these findings of computational studies can even guide the 
design and development of nanomaterial in the biomedical applications including 
disease diagnosis and treatment.  
 
2. Carbon nanomaterial 
 
Carbon nanomaterial is one of the most important inorganic nanomaterials, which 
includes graphene, fullerene, carbon nanotube, etc. A variety of carbon nanomaterials 
exhibit diversified bioapplications, such as drug and gene delivery, contrast agents, 
therapeutic agents, and components of biosensors.
[17-21]
 On the other hand, the inhaled 
carbon nanomaterials may lead to stress, inflammation, lung insult and a variety of 
cardiovascular effects.
[22-28]
 There are growing numbers of computational studies to 
investigate the mechanisms behind the spectrum of biological effects. Because of their 
well-defined structure, carbon nanomaterials also serve as the representative 
hydrophobic nanomaterials in the pioneering studies about the protein-nanomaterial 
interaction. To our knowledge, one of the first simulation works on the 
protein-nanomaterial interaction is to study the binding of fullerene C60 to 
antibody.
[29]
 Jianpeng Ma and co-workers found C60 interacts with antibody and 
forms the complex with high affinity and specificity. The binding is attributed to 
shape complementarity and extensive side-chain interaction, including hydrophobic 
and π-stacking interactions. Since such binding mode is similar to many other 
protein–ligand complexes, C60 may competitively interact with protein binding site 
and disturb the protein-ligand recognition.  
 
2.1 Fullerene derivative, Gd@C82(OH)22 
 
Fullerene is the carbon cage with the diameter of around 1 nm. It has been widely 
exploited in the fields of bioimaging, drug delivery and antitumor therapy,
[30-32] while 
the poor aqueous solubility of fullerene poses challenges to their further applications. 
And there have been a variety of fullerene derivatives, for example, fullerene can be 
hydroxylated to fullerenol. Surface modification not only improves their solubility, 
but also endows additional feature to fullerenes. Moreover, metal ion can be 
embedded in the carbon cage of fullerenol to form metallofullerenol. In general, 
metallofullerenol shares similar surface properties with fullerenol, while the 
embedded metal atom gives rise to unique properties of metallofullerenol,
[33-36]
 as will 
be discussed below. 
 
Figure 1. Interactions of Gd@C82(OH)22 with proteins. (A, left) Representative binding mode (solid ball) as well as 
alternative mode (gray ball) of Gd@C82(OH)22. (right) the binding dynamics can be characterized as three phases. 
Adapted with permission from Ref. [40]. Copyright 2012 National Academy of Sciences, USA. (B, left) 
Representative snapshot of the tropocollagen molecule bound by Gd@C82(OH)22. Snapshot of the tropocollagen 
tetramer (middle) and the tetramer bound by Gd@C82(OH)22 (right). Reproduced from Ref. [46] with permission 
from The Royal Society of Chemistry.  
 
Experimental studies have shown that a typical endohedral metallofullerenol, 
Gd@C82(OH)22 can effectively inhibit tumor growth with low toxicity both in vivo 
and in vitro.
[37,38]
 After the treatment of Gd@C82(OH)22 the thickness and flexibility 
of the fibrous layer surrounding tumor significantly increase, leading to the formation 
of a fibrous cage to imprison the tumor tissue and prevent its metastasis. The impact 
on the fibrous layer thickness can be largely attributed to the suppression of the 
expression of matrix metalloproteinases (MMPs) as well as the reduction of their 
activities.
[39,40]
 In order to elucidate this important mechanism involved in the 
antitumor effect of metallofullerenol, Ruhong Zhou and co-workers studied the 
interaction of Gd@C82(OH)22 with MMP-9 and its impact on the protein function.
[40]
 
Metallofullerenol can firmly bind to protein, while does not disturb its structure. 
Interestingly, instead of direct interaction with catalytic Zn
2+
 ion, Gd@C82(OH)22 was 
found to allosterically modulate the S1’ ligand-specificity loop which might interfere 
with the incoming substrate. In other words, metallofullerenol inhibits the activity of 
MMP-9 in an indirect way. Moreover, the authors successfully characterized the 
complete binding process as three stages, and identified the critical interaction of each 
stage.  
 
In addition to its impacts on the fibrous layer thickness, Gd@C82(OH)22 was found to 
affect the structure and biophysical properties of collagen fiber,
[39]
 the major 
component of fibrous layer.
[41-45]
 The fibrous layer become softer after the treatment, 
and this is also an important antitumor mechanism of metallofullerenol. Given by this, 
we investigated the interaction of Gd@C82(OH)22 with molecular collagen 
(tropocollagen molecule), and its impact on the structure and assembly of protein.
[46]
 
Gd@C82(OH)22 can strongly bind to tropocollagen, largely due to the hydrogen bond 
interaction with protein. Adhered Gd@C82(OH)22 can enhance the stability of native 
triple helical structure of tropocollagen and facilitate the protein assembly. 
Interestingly, the interaction of nanoparticle with protein was often considered to 
disturb protein structure or induce abnormal assembly,
[47-50]
 while, as indicated in our 
work, nanoparticle may also enhance the native structure and assembly of protein. In 
the early stage of collagen fiber formation, Gd@C82(OH)22 can form hydrogen bonds 
with multiple tropocollagen molecules acting as a “fullerenol-mediated bridge” and 
enhance the interaction among collagen molecules over the course of fiber 
nucleation.
[51-56]
. While, during the growth of collagen fiber metallofullerenol may 
interfere the interactions among proteins and affect the structure and stiffness of 
collagen fibril layer. 
 
2.2 Carbon nanotube, CNT 
Carbon nanotube (CNT) is another widely used carbon nanomaterial,
[57]
 it shares 
similar challenges (e.g. poor solubility) and potential as the fullerene counterparts, 
such as drug design, drug delivery, tumor therapy, tissue engineering, DNA 
recognition, and biosensor design.
[58-62]
 Besides, CNT is often used as a representative 
hydrophobic nanoparticle to study the role hydrophobic interaction plays in the 
protein-nanoparticle interaction, and the impact on the protein structure and function.  
 Figure 2. Impacts of CNTs on protein function. (A, left) The binding of SWCNT hinders the interaction between 
YAP65 (green) and its native ligand PRM (navy). (right) The interaction mode of SWCNT. The binding scaffold 
residues are highlighted as red sticks. Adapted with permission from Ref. [48]. Copyright 2010 American 
Chemical Society. (B, left) Representative configuration of CNT-CaM complex and the definition of the 
end-to-end distance of inter-domain linker (right) Difference in the end-to-end distance between two states. Inset: 
End-to-end distances of inter-domain linker in different complexes. Reproduced from Ref. [68] with permission 
from The Royal Society of Chemistry. 
 
Ruhong Zhou and co-workers took WW domains (i.e. YAP65, YJQ8, and PIN1) as 
examples to study the interaction of CNT with protein and the subsequent impact on 
the protein activity.
[48]
 As signaling and regulatory proteins, WW domains can 
identify and bind to the proline-rich motifs (PRMs).
[63-67]
 The authors found CNT can 
plug into hydrophobic core of WW domains because of the interaction with 
hydrophobic residues. More importantly, the binding of CNT blocks PRM active site 
and thus hinders the interaction of PRM with WW domain.  
 
Besides direct blockage of protein active site, the impact of CNT on protein function 
can be attributed to other mechanisms. Recently,
[68]
 we investigated the binding of 
CNT to calmodulin (CaM) and its impact on Ca
2+
-dependent dynamic properties of 
CaM. In addition, the size dependence of CNT’s biological effect was studied. CaM 
plays a crucial role in the calcium signal transduction pathway.
[69]
 It can bind to a 
large variety of enzymes in a Ca
2+
-dependent manner:
[70,71]
 Ca
2+
 facilitates ligand 
binding by enhancing hydrophobic interactions between ligand and protein;
[72-75]
 and 
the ion removal triggers ligand dissociation. We found CNTs can recognize the 
hydrophobic binding pocket of CaM. While small CNT shows a similar behavior to 
the native substrate M13 peptide in its dissociation from Ca
2+
-free CaM, wider CNTs 
keep binding to CaM in the absence of Ca
2+
, indicating a potential failure of Ca
2+
 
regulation and the inhibition of calcium-dependent signal transduction pathway. Such 
size-dependent impact on protein dynamic properties is largely due to the fact that the 
hydrophobic interaction of wider CNTs with protein is strong enough and does not 
require the assistance of Ca
2+
. Hence, the binding of wider CNT can dodge the 
regulation of Ca
2+
. The simulation results about the binding of CNT and the failure of 
Ca
2+
 regulation were further confirmed by circular dichroism spectroscopy.  
 
2.3 Graphene 
Graphene is a 2D plate-like carbon material with a series of extraordinary structural, 
mechanical and electronic properties.
[76]
 There are growing numbers of researches to 
explore the biomedical applications of graphene and its interaction with biological 
system.
[77]
 Zuo et al. used molecular dynamics simulation to investigate the 
adsorption of protein villin headpiece (HP35) onto graphene.
[78]
 HP35 protein is 
composed of three-helix bundle and most of its native secondary and tertiary 
structures change after the adsorption. The adsorption stability is largely attributed to 
the π-stacking interaction between graphene and the aromatic residues of protein. 
Moreover, because of its softness the shape of graphene can adapt to the distribution 
of aromatic residues and form strong π-stacking with protein. The authors also 
compared with the interaction between HP35 and CNT as well as C60, and found that 
the surface curvature of nanomaterials with same chemical component can affect their 
interaction mode with proteins. In addition to the study about protein adsorption, the 
interaction between graphene and phospholipid, another kind of important biological 
molecule, has attained intensive attention. Zhou and co-workers found the graphene 
can extract phospholipids from membrane and destroy membrane structure.
[79]
 
Meanwhile, Gao and co-workers systematically investigated the insertion and entry of 
graphene into membrane.
[80]
  
 
3. Gold nanomaterial 
Noble metal nanomaterials possess a variety of unique physical properties, they can 
serve as typical systems to study the quantum confinement effect. Because of their 
stable chemical property and high biocompatibility, gold nanomaterials become one 
of the most popular noble metal nanomaterials. With the rapid progress in the 
synthesis and modification of gold nanomaterial, there have been a wide spectrum of 
gold nanomaterials including nanorods, nanoclusters, nanobelts, nanostars and 
polyhedral nanoparticles. The distinct optical properties of gold nanomaterials 
engender their potential applications in the biomedical imaging, sensing, as well as 
photothermal therapy. And the studies about the interaction of gold nanomaterials 
with biological molecules are highly demanded.  
 
Figure 3. Gold nanoparticles interacting with proteins. (A) The binding of BSA to Au (111) surface of AuNRs. 
Three domains of BSA are colored in cyan, red, blue; and disulfides are highlighted as yellow spheres. Adapted 
with permission from Ref. [92]. Copyright 2013 American Chemical Society. (B) The AuNC–TrxR1 complex. The 
gold atoms, peptide chain, Cys/Sec residues of active site are in orange, green and yellow respectively. Reproduced 
from Ref. [112] with permission from The Royal Society of Chemistry. (C) Designed near-infrared (NIR) 
fluorescent hybrid nanocomposite: multiple AuNCs within the cage of H-ferritin (HFt). This designed probe can 
realize kidney targeting and NIR imaging of live animal. Adapted with permission from Ref. [110]. Copyright 
2015 American Chemical Society. 
 
3.1 Gold nanorod 
The sizes of gold nanorod, AuNR, are 10-20 nm in width and 10-100 nm in length. 
The optical adsorption of AuNR can be effectively regulated by changing its aspect 
ratio.
[81]
 The optical properties of gold nanorod form the basis for biomedical 
applications, and their potential impacts on living systems are then attracting much 
attention.
[82,83] The protein corona assembled on the surface of AuNR during its 
metabolic process modulates the biological responses by mitigating the 
cytotoxicity,
[84-87]
 changing the biodistribution
[88-90]
 and flammatory response of 
AuNR.
[91]
 As the most abundant serum protein, Bovine Serum Albumin (BSA) is the 
important component of corona. The study about its adsorption on AuNR is critical to 
understand the formation of protein corona. Previous experimental studies have 
shown that BSA can stably bind to the surface of AuNR and improve its 
biocompatibility,
[92]
 while the detailed molecular mechanism and the corresponding 
structure still remain elusive. We combined the experimental synchrotron radiation 
(SR)-based analytical techniques
[93-97]
 with molecular dynamics simulation to 
investigate the interaction mode of BSA corona with AuNR. It has been well accepted 
that the binding of BSA is largely attributed to the Au-S coordination between the 
gold atoms and sulfur atoms of cysteine residues. There are 17 disulfide bonds 
between cysteine residues in BSA, most of which are exposed to solvent. We found 
there are 8 disulfide bonds distributed around a plane, denoted to plane S. The 
adsorption process of BSA was further investigated by molecular dynamics simulation. 
The plane S can serve as the binding interface, and there are at least 12 Au-S 
coordination bonds form during the adsorption. These findings were confirmed by SR 
S K-edge X-ray absorption near-edge structures (XANES)
[98]
 and SR-based 
microbeam X-ray fluorescence
[99-101]
 (XRF) results. In addition, our study proposes 
such combined approach can effectively study the interfacial interactions of protein 
corona with AuNR, which should improve the understanding about the nature of 
corona’s protective effects. 
 
3.2 Gold nanocluster 
Gold nanocluster, AuNC, is composed of a few to roughly a hundred atoms with the 
diameter below 2 nm. And the properties of AuNC are distinct to both isolated atoms 
and larger nanoparticles.
[102]
 As a representative fluorescent nanomaterial, AuNC 
becomes attractive to biolabeling and bioimaging applications owing to its ultra-small 
size, nontoxicity and highly fluorescent properties.
[103-105]
 In order to improve their 
suspension stability, AuNCs are often protected with various coatings such as 
alkanethiols, DNAs, peptides or even within protein cage,
[106-109]
 resulting in the 
bioinorganic hybrid nanomaterials. The coatings can also modulate the surface 
properties of AuNC and improve its biocompatibility.  
 
As indicated in the previous work of our collaborators, ferritin protein cage can guide 
the formation of gold nanoclusters, leading to the gold cluster-based hybrid 
nanocomposite.
[110]
 Ferritin complex is composed of 24 monomers with two types, i.e. 
heavy chain and light chain (H- and L-ferritin, respectively). According to our 
simulation result, the nucleation sites of gold clusters locate in His-rich surface region 
of H-ferritin, HFt. The interaction of gold atoms with imidazole group of histidine 
facilitates the formation of gold cluster. Accordingly, our collaborators used the 
protein nanocage composed of all HFts to synthesize the hybrid nanocomposite 
containing 24 AuNCs. The number of nanoclusters within nanocage was confirmed by 
cryo-EM image. Moreover, such Au-HFt nanocomposite can serve as near infrared 
(NIR) probe with high fluorescent yield, showing powerful tissue penetrating ability. 
Because of the kidney targeting ability of ferritin, this designed NIR Au-HFt probe 
may be exploited in kidney disease diagnosis of live animal. 
 
More interestingly, AuNC can directly bind to target protein and affect the protein 
activity, exhibiting the potential in disease treatment. Our collaborator synthesized 
peptide coated Au25 cluster,
[111]
 and found the AuNC can specifically bind to 
Thioredoxin Reductase1, TrxR1.
[112]
 TrxR1 is important to the regulation of cellular 
redox level and often overexpressed in cancer cells.
[113,114]
 The protein has been well 
recognized as the potential target for the anti-tumor therapeutic agent.
[115,116]
 The 
treatment of peptide-coated AuNC was found to effectively suppress the protein 
activity, resulting in the increased concentration of reactive oxygen species and the 
subsequent apoptosis of tumor cells. The potential of peptide-coated AuNC in tumor 
therapy requires the detailed study about the corresponding mechanism especially the 
interaction mode of AuNC with protein. We firstly used molecular docking method
[117]
 
to search the binding site throughout the surface of TrxR1 and successfully identified 
a putative binding region around the active site Cys497-Sec498 (Sec, selenocysteine). 
Additional molecular dynamics simulation was then performed to assess the binding 
stability of AuNC. In general, the AuNC can directly bind to the region around active 
site, mainly due to electrostatic attraction between positively charged coating peptides 
and negatively charged surface residues around the active site. Besides, the hydrogen 
bond and hydrophobic interactions are also involved in the binding of such coated 
AuNC, which facilitates the subsequent coordination interaction of Au25 cluster with 
cysteine and selenocysteine.
[118]
 Taken together, such AuNCs can selectively 
recognize TrxR1 in vivo. The studies about molecular mechanism of these biological 
effects may be inspiring to the design of therapeutic gold nanoparticles against disease 
involving TrxR1, e.g. cancer. 
 
4. Conclusions  
 
In this paper, we reviewed recent computational studies about interaction of protein 
with carbon and gold nanomaterials. The interaction of carbon nanomaterial with 
protein is largely attributed to the hydrophobic and π-stacking interactions. While the 
binding of protein to pristine gold nanomaterial mainly results from Au-S 
coordination as well as the interaction with imidazole group of histidine, the gold 
nanomaterials are often modified by various coatings and the interaction mode of 
coated gold nanomaterial also involves electrostatic, hydrophobic and hydrogen bond 
interactions.  
 
The interaction with nanomaterial often results in the influence on protein activity. 
For example, CNT can interact with the active site of WW domain and hinder the 
interaction with native ligand. Besides, the binding of CNT can interrupt the dynamic 
properties of CaM in a size-dependent manner. On the other hand, the impacts of 
nanomaterial on the protein structure and activity provide possible resolutions to the 
disease treatment. Metallofullerenol Gd@C82(OH)22 was found to effectively inhibit 
tumor growth by increasing the thickness and flexibility of fibrous layer to “prison” 
cancer cells. The anti-tumor effect of Gd@C82(OH)22 involves multiple target proteins. 
The expression and activity of matrix metalloproteinases are down regulated by 
nanoparticle. In addition, Gd@C82(OH)22 can affect the structure and assembly of 
molecular collagen which should lead to the reduced stiffness of collagen fibrous 
layer.  
 
Because of their fast growing applications in biomedical studies, the interaction of 
gold nanomaterial with protein has also attained wide interests. The importance of 
Au-S coordination in such systems has been well recognized, and the binding 
behavior of some proteins depends on the distribution of exposed cysteine residues 
and can be captured by experimental techniques like S K-edge XANES. The binding 
of peptide-coated AuNC to the cysteine-containing active site of TrxR1 results in the 
inhibition of protein activity and the apoptosis of cancer cell. On the other hand, the 
imidazole group of histidine is also involved in the interaction with gold nanoparticles. 
For example, histidine-rich surface region of HFt can guide the nucleation and growth 
of AuNCs.  
 
In short, complicated nature of metabolite process of nanomaterial poses the challenge 
to study their interactions with protein in vivo. On the other hand, computational 
studies can effectively investigate the mechanisms about the interaction of 
nanomaterial with protein and the subsequent impact on protein activity, and explain 
the underlying mechanisms of biological effects. As described above, nanomaterials 
often interact with multiple target proteins and the modulation of protein activity can 
be attributed to a wide spectrum of mechanisms. In addition, simulation results can 
further guide the design of nanomaterial to integrate functionality and/or enhance the 
desired properties of nanomaterial.  
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